when will coronavirus vaccine come in hindi why the corona vaccine is taking time sputnik-v update
when will coronavirus vaccine come
when will coronavirus vaccine be ready
when will coronavirus vaccine be out in india
why the corona vaccine is taking time
why the corona vaccine is taking so long
sputnik v
sputnik v vaccine
sputnik v vaccine update
Indian govt to aid phase 3 trials of Russia’s covid vaccine
The government is willing to facilitate a phase 3 trial for Russia’s Sputnik V vaccine for which 2-4 Indian companies are in discussions to mass manufacture, NITI Aayog member (health) V.K. Paul said on Tuesday.
“The outreach has been extended to several companies in India, and 2-4 of them have already come forward. Others are in discussion with the Russian counterparts and the government is facilitating that process. Yes, there would be a need for a phase 3 trial in normal course of things, and if that is required, we are paving way that such a phase 3 trial, or bridging studies, as required per science and India’s regulatory system, would be facilitated by the government,” Paul said.
The Indian vaccine manufacturers are in talks with Russia’s Gamaleya National Research Center of Epidemiology and Microbiology for mass manufacturing of the ‘Sputnik V’ vaccine, which was the world’s first registered covid-19 vaccine.
However, as the phase 3 trials for the vaccine have not been completed, the Indian firm who will manufacture the vaccine may have to conduct the study in India, Paul said.
Russia’s recently approved covid-19 vaccine, Sputnik V, appears to be safe without any serious adverse effects, and developed long-term antibody response in humans during phase 1 and 2 clinical trials among 76 subjects, according to preliminary results published in The Lancet journal last week.
The government has also mapped manufacturing capacities of various vaccine makers and expects Serum Institute of India to produce 75-100 million doses per month of covid-19 vaccines.
“We have done mapped what the potential capacities are, but it is changing dynamically because there are at least 7-8 other companies, who if they get an offer or if they have their own vaccine, they will also get into the picture,” Paul said at a press conference on Tuesday.
Paul, as the chairman of the National Expert Committee on Vaccine Administration, has held discussions with five manufacturers–Serum Institute, Zydus Cadila, Bharat Biotech International, Biological E and Gennova Biopharmaceuticals—about capacities, manufacturing timelines, procurement and financing.
Serum Institute, the world’s largest vaccine manufacturer by volume, has said it will produce around 1 billion doses of the covid-19 vaccine jointly developed by the University of Oxford and Astrazeneca plc. The Pune-based firm is currently conducting a 1,600-participanyt phase 3 clinical trial of the vaccine across 17 hospitals in India.
Bharat Biotech International Ltd has also started the second phase of clinical trials of its covid-19 vaccine Covaxin, while Zydus Cadila’s phase 2 study is underway, Paul said.
corona vaccine clinical trial
corona vaccine update
corona vaccine update in hindi
corona vaccine news
corona vaccine trial
corona vaccine hindi
corona vaccine kab tak aayega
corona vaccine aa gayi
kya corona ki vaccine aa gayi hai
kya corona virus ki vaccine aa gayi hai
when will coronavirus vaccine came in hindi
coronavirus ki vaccine
coronavirus ki vaccine kab aayegi
coronavirus ki vaccine kab tak banegi
corona vaccine clinical trial
To know more please watch the video till the end and if you like then don’t forget to subscribe & share my YouTube channel ‘DrugDaddy’
Thank You
#when_will_coronavirus_vaccine_come
#drugdaddy
#sputnikv
#pharmacynearme
*********************************************************
Follow Us On Our Social Media Links:
Instagram : DrugDaddy
@drugdaddysg :
Facebook Page : DrugDaddy
@DrugDaddy :
